Thc Farmaceuticals Stock Performance
| CBDG Stock | USD 0.04 0.02 90.00% |
THC Farmaceuticals holds a performance score of 14 on a scale of zero to a hundred. The entity owns a Beta (Systematic Risk) of -5.17, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning THC Farmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, THC Farmaceuticals is expected to outperform it. Use THC Farmaceuticals treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to analyze future returns on THC Farmaceuticals.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in THC Farmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, THC Farmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point. ...more
THC |
THC Farmaceuticals Relative Risk vs. Return Landscape
If you would invest 1.31 in THC Farmaceuticals on October 3, 2025 and sell it today you would earn a total of 2.49 from holding THC Farmaceuticals or generate 190.08% return on investment over 90 days. THC Farmaceuticals is currently generating 9.3379% in daily expected returns and assumes 52.7951% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than THC, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
THC Farmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for THC Farmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as THC Farmaceuticals, and traders can use it to determine the average amount a THC Farmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1769
| Best Portfolio | Best Equity | CBDG | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average THC Farmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of THC Farmaceuticals by adding it to a well-diversified portfolio.
THC Farmaceuticals Fundamentals Growth
THC Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of THC Farmaceuticals, and THC Farmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on THC Pink Sheet performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0496 | |||
| Operating Margin | (3.78) % | |||
| Current Valuation | 8.18 M | |||
| Shares Outstanding | 15 M | |||
| Price To Earning | (109.90) X | |||
| Price To Book | 7.39 X | |||
| Price To Sales | 396.80 X | |||
| Revenue | 19.03 K | |||
| EBITDA | (69.42 K) | |||
| Cash And Equivalents | 30.55 K | |||
| Total Debt | 77.7 K | |||
| Debt To Equity | 0.67 % | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (18.9 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 48.15 K | |||
| Retained Earnings | (204 K) | |||
| Current Asset | 32 K | |||
| Current Liabilities | 16 K | |||
About THC Farmaceuticals Performance
By analyzing THC Farmaceuticals' fundamental ratios, stakeholders can gain valuable insights into THC Farmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if THC Farmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if THC Farmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc. City Media operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about THC Farmaceuticals performance evaluation
Checking the ongoing alerts about THC Farmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for THC Farmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| THC Farmaceuticals is way too risky over 90 days horizon | |
| THC Farmaceuticals has some characteristics of a very speculative penny stock | |
| THC Farmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 19.03 K. Net Loss for the year was (30.7 K) with profit before overhead, payroll, taxes, and interest of 6.73 K. | |
| THC Farmaceuticals currently holds about 30.55 K in cash with (18.9 K) of positive cash flow from operations. |
- Analyzing THC Farmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether THC Farmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining THC Farmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating THC Farmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of THC Farmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of THC Farmaceuticals' pink sheet. These opinions can provide insight into THC Farmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for THC Pink Sheet analysis
When running THC Farmaceuticals' price analysis, check to measure THC Farmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Farmaceuticals is operating at the current time. Most of THC Farmaceuticals' value examination focuses on studying past and present price action to predict the probability of THC Farmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Farmaceuticals' price. Additionally, you may evaluate how the addition of THC Farmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |